🔗 Permalink

Assignee profile:

Bayer Pharma Aktiengesellschaft

City:

Berlin

Country:

Germany

Published Applications:

545

Last publication date:

2026-01-15

Patent Grants:

377

Last grant date:

2025-11-25

Quarterly Bayer Pharma Aktiengesellschaft Patent Applications

Top Inventors for applications by Bayer Pharma Aktiengesellschaft

These are the the leading inventors for applications assigned to Bayer Pharma Aktiengesellschaft:

Philip Lienau 65 Berlin, Germany
Gerhard Siemeister 52 Berlin, Germany
Frank WUNDER 49 Wuppertal, Germany
Adrian TERSTEEGEN 45 Wuppertal, Germany

Alexandros Vakalopoulos 40 Hilden, Germany
Katja Zimmermann 35 Dusseldorf, Germany
Hanna TINEL 35 Wuppertal, Germany
Ulf Bömer 34 Glienicke, Germany

Hans Briem 32 Berlin, Germany
Antje Margret Wengner 32 Berlin, Germany
Karl-Heinz Schlemmer 32 Wuppertal, Germany
Niels LINDNER 31 Wuppertal, Germany

Anja Buchmüller 30 Essen, Germany
Volkhart Min-Jian LI 30 Velbert, Germany
Martina SCHÄFER 30 Berlin, Germany
Knut Eis 29 Berlin, Germany

Benjamin Bader 28 Berlin, Germany
Anja BUCHMÜLLER 28 Essen, Germany
Hans-Georg Lerchen 28 Leverkusen, Germany
Ulrich Klar 27 Berlin, Germany

Markus Follmann 27 Koln, Germany
Susanne Röhrig 27 Hilden, Germany
Johannes-Peter Stasch 26 Solingen, Germany
Gorden Redlich 26 Bochum, Germany

Yolanda CANCHO GRANDE 26 Leverkusen, Germany
Dieter Lang 26 Velbert, Germany
Klemens LUSTIG 26 Wuppertal, Germany
Christoph GERDES 26 Koln, Germany

Johannes Platzek 26 Berlin, Germany
Ulf BÖMER 26 Glienicke, Germany
Peter Kolkhof 25 Wuppertal, Germany
Jens ACKERSTAFF 25 Dusseldorf, Germany

Ulrich Lucking 25 Berlin, Germany
Tobias Marquardt 25 Wuppertal, Germany
Martina Schäfer 24 Berlin, Germany
Susanne RÖHRIG 24 Hilden, Germany

Ludwig Zorn 24 Berlin, Germany
Stefan Heitmeier 23 Wulfrath, Germany
Alexander HILLISCH 23 Solingen, Germany
Simon Holton 23 Berlin, Germany

Alexander Straub 23 Wuppertal, Germany
Lisa Dietz 23 Wuppertal, Germany
Andreas KNORR 23 Erkrath, Germany
Arne Scholz 22 Berlin, Germany

Michael HAHN 22 Langenfeld, Germany
Martin LANGE 21 Berlin, Germany
Ulrich Bothe 21 Berlin, Germany
Christian Stegmann 20 Berlin, Germany

Holger Siebeneicher 20 Berlin, Germany
Carsten TERJUNG 20 Bochum, Germany
Heiko SCHIRMER 20 Solingen, Germany
Martina Victoria SCHMIDT 20 Köln, Germany

Judith GÜNTHER 20 Berlin, Germany
Julia Straßburger 20 Wuppertal, Germany
Wilhelm Bone 20 Berlin, Germany
Elisabeth Pook 20 Wuppertal, Germany

Dmitry Zubov 20 Remscheid, Germany
Beatrix Stelte-Ludwig 20 Wulfrath, Germany
Dirk Kosemund 20 Berlin, Germany
Martina Delbeck 19 Heiligenhaus, Germany

Anne-Sophie REBSTOCK 19 Champagne au Mont d'Or, France
Simone Greven 19 Dormagen, Germany
Carsten Schmeck 19 Mulheim, Germany
Roland Neuhaus 18 Berlin, Germany

Detlef STÖCKIGT 18 Potsdam, Germany
Christoph Mahlert 18 Wuppertal, Germany
Amaury Ernesto Fernandez-Montalvan 18 Berlin, Germany
Raimund Kast 18 Wuppertal, Germany

Detlev Sülzle 18 Berlin, Germany
Reinhard Nubbemeyer 18 Berlin, Germany
Henrik TELLER 17 Schwaan, Germany
Andrea Rotgeri 17 Berlin, Germany

Norbert Schmees 17 Berlin, Germany
Ningshu Liu 17 Berlin, Germany
Anne Mengel 17 Berlin, Germany
Olaf Panknin 17 Berlin, Germany

Marcus Koppitz 17 Berlin, Germany
Chantal Furstner 16 Mulheim/Ruhr, Germany
Eckhard Bender 16 Langenfeld, Germany
Holger STEUBER 16 Berlin, Germany

Ulrich LÜCKING 16 Berlin, Germany
Ulrike RÖHN 16 Berlin, Germany
Thomas NEUBAUER 16 Wuppertal, Germany
Kirstin Petersen 16 Berlin, Germany

Markus BERGER 16 Berlin, Germany
Eva Maria BECKER-PELSTER 15 Wuppertal, Germany
Mark Jean GNOTH 15 Mettmann, Germany
Detlev SÜLZLE 15 Berlin, Germany

Manuel ELLERMANN 15 Berlin, Germany
Detlef Stöckigt 15 Potsdam, Germany
Thomas MÜLLER 14 Langenfeld, Germany
Keith Graham 14 Berlin, Germany

Judith Günther 14 Berlin, Germany
Dirk Schneider 14 Wuppertal, Germany
Ursula MÖNNING 14 Woltersdorf, Germany
Jens SCHRÖDER 14 Berlin, Germany

Kersten Matthias Gericke 14 Wuppertal, Germany
Kai LOVIS 13 Düsseldorf, Germany
Lars Wortmann 13 Berlin, Germany
Matthias Beat WITTWER 13 Riehen, Switzerland

Recent patent applications by Bayer Pharma Aktiengesellschaft

Bayer Pharma Aktiengesellschaft based in Berlin, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-01-15

US20260015355A1

Chemistry; metallurgy

METHOD FOR THE PREPARATION OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1-6-NAPHTHYRIDINE-3-CARBOX-AMIDE BY RACEMATE SEPARATION BY MEANS OF DIASTEREOMERIC TARTARIC ACID ESTERS

#2 | 2025-11-06

US20250340553A1

Chemistry; metallurgy

#3 | 2025-05-15

US20250154175A1

Chemistry; metallurgy

DIAZABICYCLIC SUBSTITUTED IMIDAZOPYRIMIDINES AND THEIR USE FOR THE TREATMENT OF BREATHING DISORDERS

#4 | 2025-04-10 ✅ Patent 12,478,696 granted on 2025-11-25

US20250114485A1

Human necessities

GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING

#5 | 2025-01-30 ✅ Patent 12,559,473 granted on 2026-02-24

US20250034111A1

Chemistry; metallurgy

SUBSTITUTED INDAZOLES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS THAT CONTAIN SAID NEW SUBSTITUTED INDAZOLES, AND USE OF SAID NEW SUBSTITUTED INDAZOLES TO PRODUCE DRUGS

#6 | 2024-11-21

US20240382495A1

Human necessities

COMBINATIONS OF COPANLISIB WITH ANTI-PD-1 ANTIBODY

#7 | 2024-11-14

US20240376103A1

Chemistry; metallurgy

#8 | 2024-11-07

US20240366620A1

Human necessities

COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATION AND CANCER TREATMENT

#9 | 2024-09-05 ✅ Patent 12,522,594 granted on 2026-01-13

US20240294505A1

Chemistry; metallurgy

2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER

#10 | 2024-08-01 ✅ Patent 12,303,573 granted on 2025-05-20

US20240252690A1

Human necessities

Formulation of contrast media and process of preparation thereof

#11 | 2024-06-06

US20240182452A1

Chemistry; metallurgy

6-PHENYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE3A AND PDE3B INHIBITORS FOR TREATING CANCER

#12 | 2024-05-09 ✅ Patent 12,138,256 granted on 2024-11-12

US20240148715A1

Human necessities

Treatment of cardiopulmonary disorders

#13 | 2024-04-18 ✅ Patent 12,503,491 granted on 2025-12-23

US20240124522A1

Chemistry; metallurgy

MASP INHIBITORY COMPOUNDS AND USES THEREOF

#14 | 2024-04-11 ✅ Patent 12,202,805 granted on 2025-01-21

US20240116874A1

Chemistry; metallurgy

Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound

#15 | 2023-12-28

US20230416249A1

Chemistry; metallurgy

N-[2-({4-[3-(ANILINO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]PYRIDIN-3-YL)OXY)ETHYL]PROP-2-ENAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER

#16 | 2023-11-16 ✅ Patent 12,486,248 granted on 2025-12-02

US20230365524A1

Chemistry; metallurgy

2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH

#17 | 2023-11-02

US20230346927A1

Human necessities

COMBINATION of ATR KINASE INHIBITORS and PD-1/PD-L1 INHIBITORS

#18 | 2023-08-31 ✅ Patent 12,239,630 granted on 2025-03-04

US20230271931A1

Chemistry; metallurgy

Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor

#19 | 2023-06-29 ✅ Patent 11,998,539 granted on 2024-06-04

US20230201186A1

Human necessities

Substituted aminoquinolones as DGKalpha inhibitors for immune activation

#20 | 2023-06-08 ✅ Patent 12,006,303 granted on 2024-06-11

US20230174508A1

Chemistry; metallurgy

Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs

#21 | 2023-05-11 ✅ Patent 12,478,621 granted on 2025-11-25

US20230148194A1

Human necessities

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION

#22 | 2023-04-20 ✅ Patent 11,795,164 granted on 2023-10-24

US20230121195A1

Chemistry; metallurgy

2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer

#23 | 2023-04-13

US20230113037A1

Chemistry; metallurgy

[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES

#24 | 2023-04-13 ✅ Patent 11,891,404 granted on 2024-02-06

US20230112244A1

Chemistry; metallurgy

Substituted macrocyclic indole derivatives

#25 | 2023-03-23 ✅ Patent 11,905,270 granted on 2024-02-20

US20230086179A1

Chemistry; metallurgy

Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor

#26 | 2023-03-02

US20230065629A1

Chemistry; metallurgy

SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF

#27 | 2023-03-02

US20230064809A1

Human necessities

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION

#28 | 2023-03-02

US20230062100A1

Human necessities

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION

#29 | 2023-02-09 ✅ Patent 12,023,319 granted on 2024-07-02

US20230043209A1

Human necessities

Carboxylic acid aromatic amides

#30 | 2023-02-09 ✅ Patent 12,144,865 granted on 2024-11-19

US20230039341A1

Human necessities

Antibody drug conjugates with enzymatically cleavable groups

#31 | 2023-01-19 ✅ Patent 12,258,323 granted on 2025-03-25

US20230017200A1

Chemistry; metallurgy

Dihydrooxadiazinones

#32 | 2023-01-19

US20230013419A1

Chemistry; metallurgy

ANALOGUES OF 3-(5-METHYL-1,3-THIAZOL-2-YL)-N-{(1R)-1-[2-(TRIFLUORO-METHYL)PYRIMIDIN-5-YL]ETHYL}BENZAMIDE

#33 | 2022-12-15 ✅ Patent 11,773,070 granted on 2023-10-03

US20220396554A1

Chemistry; metallurgy

Dihydrooxadiazinones

#34 | 2022-12-08 ✅ Patent 12,006,304 granted on 2024-06-11

US20220388982A1

Chemistry; metallurgy

Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs

#35 | 2022-11-10

US20220356194A1

Chemistry; metallurgy

PROCESS FOR PREPARING BENZOTHIOPHEN-2YL BORONATE

#36 | 2022-11-08 ✅ Patent 11,492,358 granted on 2022-11-08

US17186820

Chemistry; metallurgy

Macrocyclic indole derivatives

#37 | 2022-10-25 ✅ Patent 11,478,451 granted on 2022-10-25

US16764565

Human necessities

Macrocyclic chlorine substituted indole derivatives

#38 | 2022-10-13 ✅ Patent 11,524,938 granted on 2022-12-13

US20220324807A1

Chemistry; metallurgy

Aromatic sulfonamide derivatives

#39 | 2022-09-08 ✅ Patent 12,152,041 granted on 2024-11-26

US20220281891A1

Chemistry; metallurgy

Macrocyclic fluorine substituted indole derivatives

#40 | 2022-09-01

US20220274979A1

Chemistry; metallurgy

2-METHYL-AZA-QUINAZOLINES

#41 | 2022-08-25 ✅ Patent 11,643,469 granted on 2023-05-09

US20220267457A1

Chemistry; metallurgy

Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies

#42 | 2022-08-25 ✅ Patent 11,691,986 granted on 2023-07-04

US20220267353A1

Chemistry; metallurgy

PTEFB inhibiting macrocyclic compounds

#43 | 2022-08-18

US20220259228A1

Chemistry; metallurgy

SUBSTITUTED DIAZAHETERO-BICYCLIC COMPOUNDS AND THEIR USE

#44 | 2022-08-18

US20220257547A1

Human necessities

ORALLY ADMINISTRABLE MODIFIED-RELEASE PHARMACEUTICAL DOSAGE FORM

#45 | 2022-08-11 ✅ Patent 11,992,481 granted on 2024-05-28

US20220249456A1

Human necessities

Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseases

#46 | 2022-08-04

US20220241261A1

Human necessities

COMBINATIONS OF INHIBITORS OF IRAK4 WITH INHIBITORS OF BTK

#47 | 2022-08-04

US20220241255A1

Human necessities

COMBINATION CONTAINING SGC ACTIVATORS AND MINERALOCORTICOID RECEPTOR ANTAGONISTS

#48 | 2022-07-28

US20220235013A1

Chemistry; metallurgy

2-METHYL-QUINAZOLINES

#49 | 2022-07-28

US20220234996A1

Chemistry; metallurgy

Method for Producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic Acid and the Crystalline Form Thereof for Use as a Pharmaceutical Ingredient

#50 | 2022-06-30 ✅ Patent 12,459,916 granted on 2025-11-04

US20220204474A1

Chemistry; metallurgy

SUBSTITUTED INDAZOLES USEFUL FOR TREATMENT AND PREVENTION OF ALLERGIC AND/OR INFLAMMATORY DISEASES IN ANIMALS

#51 | 2022-05-24 ✅ Patent 11,339,157 granted on 2022-05-24

US16758018

Chemistry; metallurgy

4H-pyrrolo[3,2-c]pyridin-4-one derivatives

#52 | 2022-05-19 ✅ Patent 12,152,006 granted on 2024-11-26

US20220153701A1

Chemistry; metallurgy

Process for preparing 4-amino-5-methylpyridone

#53 | 2022-05-19 ✅ Patent 12,358,877 granted on 2025-07-15

US20220153699A1

Chemistry; metallurgy

SYNTHESIS OF 4-AMINO-5-METHYL-1H-PYRIDIN-2(1H)-ON (INTERMEDIATE COMPOUND FOR THE SYNTHESIS OF THE MR ANTAGONIST FINERENONE) FROM 2-CHLORO-5-METHYL-4-NITRO-PYRIDINE-1-OXIDE USING THE INTERMEDIATE COMPOUND 2-CHLORO-5-METHYL-4-PYRIDINAMINE

#54 | 2022-05-12

US20220143229A1

Human necessities

RADIO-PHARMACEUTICAL COMPLEXES

#55 | 2022-05-05 ✅ Patent 11,713,304 granted on 2023-08-01

US20220135536A1

Chemistry; metallurgy

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

#56 | 2022-03-31

US20220098201A1

Chemistry; metallurgy

THE MONOHYDRATE OF ROGARATINIB HYDROCHLORIDE AND SOLID STATES THEREOF

#57 | 2022-03-24

US20220089591A1

Chemistry; metallurgy

7-SUBSTITUTED 1-ARYL-NAPHTHYRIDINE-3-CARBOXYLIC ACID AMIDES AND USE THEREOF

#58 | 2022-03-10

US20220071995A1

Human necessities

COMPOSITIONS AND METHODS FOR CANCER EXPRESSING PDE3A OR SLFN12

#59 | 2022-01-27 ✅ Patent 12,427,131 granted on 2025-09-30

US20220023246A1

Human necessities

STIMULATORS AND/OR ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE (SGC) IN COMBINATION WITH AN INHIBITOR OF NEUTRAL ENDOPEPTIDASE (NEP INHIBITOR) AND/OR AN ANGIOTENSIN AII ANTAGONIST AND THE USE THEREOF

#60 | 2022-01-20 ✅ Patent 12,180,227 granted on 2024-12-31

US20220017540A1

Chemistry; metallurgy

Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders

#61 | 2022-01-20 ✅ Patent 11,478,554 granted on 2022-10-25

US20220016258A1

Human necessities

Antibody drug conjugates (ADCS) having enzymatically cleavable groups

#62 | 2022-01-20

US20220016106A1

Human necessities

COMPOUNDS AND METHODS USEFUL FOR TREATING OR PREVENTING HEMATOLOGICAL CANCERS

#63 | 2021-12-30 ✅ Patent 11,976,334 granted on 2024-05-07

US20210404012A1

Chemistry; metallurgy

Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease

#64 | 2021-12-30

US20210401823A1

Human necessities

INHIBITORS AND ANTAGONISTS OF GPR84 FOR THE TREATMENT OF ENDOMETRIOSIS

#65 | 2021-12-23

US20210395390A1

Chemistry; metallurgy

REVERSAL AGENTS FOR NEUTRALIZING THE THERAPEUTIC ACTIVITY OF ANTI-FXIA ANTIBODIES

#66 | 2021-12-23

US20210393624A1

Human necessities

PROCESS FOR PRODUCING PHARMACEUTICAL DOSAGE FORMS CONTAINING TASK-1 AND TASK-3 CHANNEL INHIBITORS, AND THE USE OF SAME IN BREATHING DISORDER THERAPY

#67 | 2021-10-14 ✅ Patent 11,319,324 granted on 2022-05-03

US20210317128A1

Chemistry; metallurgy

Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors

#68 | 2021-09-23 ✅ Patent 11,401,278 granted on 2022-08-02

US20210292341A1

Chemistry; metallurgy

Macrocyclic indole derivatives

#69 | 2021-09-16

US20210283046A1

Human necessities

PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE

#70 | 2021-09-09 ✅ Patent 11,447,504 granted on 2022-09-20

US20210277022A1

Chemistry; metallurgy

Macrocyclic chlorine substituted indole derivatives

#71 | 2021-08-26 ✅ Patent 11,472,803 granted on 2022-10-18

US20210261541A1

Chemistry; metallurgy

7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof

#72 | 2021-08-19 ✅ Patent 12,258,343 granted on 2025-03-25

US20210253573A1

Chemistry; metallurgy

Method for preparing 2-[(3R)-3-methylmorpholin-4-yl]-4-[1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine

#73 | 2021-08-19 ✅ Patent 11,806,404 granted on 2023-11-07

US20210252161A1

Human necessities

Site specific homogeneous with KSP inhibitors

#74 | 2021-08-12 ✅ Patent 11,667,675 granted on 2023-06-06

US20210246166A1

Chemistry; metallurgy

MASP inhibitory compounds and uses thereof

#75 | 2021-08-05 ✅ Patent 12,053,476 granted on 2024-08-06

US20210236504A1

Human necessities

Compounds, compositions and methods for cancer patient stratification and cancer treatment

#76 | 2021-07-29

US20210230284A1

Chemistry; metallurgy

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND ANTI-CD123-ANTIBODIES

#77 | 2021-07-22 ✅ Patent 11,814,369 granted on 2023-11-14

US20210221798A1

Chemistry; metallurgy

HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING

#78 | 2021-07-22

US20210220358A1

Human necessities

1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH NERVE FIBER SENSITIZATION

#79 | 2021-07-22

US20210220357A1

Human necessities

1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH NERVE FIBER SENSITIZATION

#80 | 2021-06-24 ✅ Patent 11,787,797 granted on 2023-10-17

US20210188846A1

Chemistry; metallurgy

4,5-annulated 1,2,4-triazolones

#81 | 2021-06-17 ✅ Patent 11,230,540 granted on 2022-01-25

US20210179590A1

Chemistry; metallurgy

Substituted triazole derivatives and uses thereof

#82 | 2021-06-17 ✅ Patent 11,332,435 granted on 2022-05-17

US20210179541A1

Chemistry; metallurgy

Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient

#83 | 2021-06-03 ✅ Patent 12,054,481 granted on 2024-08-06

US20210163474A1

Chemistry; metallurgy

Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide by racemate separation by means of diastereomeric tartaric acid esters

#84 | 2021-05-20 ✅ Patent 11,884,660 granted on 2024-01-30

US20210147414A1

Chemistry; metallurgy

Substituted oxopyridine derivative

#85 | 2021-05-06

US20210128728A1

Human necessities

PROLACTIN RECEPTOR ANTIBODY FOR MALE AND FEMALE PATTERN HAIR LOSS

#86 | 2021-05-06 ✅ Patent 11,690,911 granted on 2023-07-04

US20210128723A1

Human necessities

Combination of ATR kinase inhibitors and PD-1/PD-L1 inhibitors

#87 | 2021-05-06 ✅ Patent 11,660,301 granted on 2023-05-30

US20210128572A1

Human necessities

Combination of ATR kinase inhibitors with PARP inhibitors

#88 | 2021-04-29 ✅ Patent 11,684,621 granted on 2023-06-27

US20210121461A1

Human necessities

Combination containing sGC stimulators and mineralocorticoid receptor antagonists

#89 | 2021-04-22 ✅ Patent 11,344,519 granted on 2022-05-31

US20210113504A1

Human necessities

Orally administrable modified-release pharmaceutical dosage form

#90 | 2021-03-25

US20210085664A1

Human necessities

USE OF 2-SUBSTITUTED INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF AUTOIMMUNE DISEASES

#91 | 2021-03-25 ✅ Patent 11,311,520 granted on 2022-04-26

US20210085656A1

Human necessities

Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitors

#92 | 2021-03-18 ✅ Patent 11,286,263 granted on 2022-03-29

US20210079018A1

Chemistry; metallurgy

Macrocyclic fluorine substituted indole derivatives

#93 | 2021-02-25

US20210053941A1

Chemistry; metallurgy

SUBSTITUTED INDAZOLES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS THAT CONTAIN SAID NEW SUBSTITUTED INDAZOLES, AND USE OF SAID NEW SUBSTITUTED INDAZOLES TO PRODUCE DRUGS

#94 | 2021-02-18

US20210047297A1

Chemistry; metallurgy

4-(3-AMINO-6-FLUORO-1H-INDAZOL-5-YL)-1,2,6-TRIMETHYL-1,4-DIHYDROPYRIDINE-3,5-DIC ARBONITRILE COMPOUNDS FOR TREATING HYPERPROLIFERATIVE DISORDERS

#95 | 2021-02-04 ✅ Patent 11,365,179 granted on 2022-06-21

US20210032212A1

Chemistry; metallurgy

Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazolone

#96 | 2021-01-28

US20210024545A1

Chemistry; metallurgy

SUBSTITUTED DIAZAHETERO-BICYCLIC COMPOUNDS AND THEIR USE

#97 | 2021-01-28

US20210024490A1

Chemistry; metallurgy

METHOD FOR THE PREPARATION OF THE METABOLITES OF (4S)- AND (4R)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE AND THE USE THEREOF

#98 | 2021-01-28

US20210023088A1

Human necessities

REDUCING THE RISK OF CARDIOVASCULAR EVENTS

#99 | 2021-01-21 ✅ Patent 11,701,347 granted on 2023-07-18

US20210015806A1

Human necessities

Use of 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large B-cell lymphoma

#100 | 2021-01-14 ✅ Patent 11,390,592 granted on 2022-07-19

US20210009534A1

Chemistry; metallurgy

Method for producing the crystalline form of modification a of calcobutrol

Also check out Bayer Pharma Aktiengesellschaft's (Berlin, Germany) applicant profile with 339 patent applications submitted.

AssigneeID:

1921 ⎘